Autotransfusion Devices Market Trends

  • Report ID: 4459
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Autotransfusion Devices Market Trends

Growth Drivers

  • Growing Burden of Chronic Disease on the World- Deaths and impairments from chronic obstructive pulmonary illness are rising across most regions. Moreover, chronic disease potential consequences are also expanding. As a result, the treatment and surgery for a wide range of chronic diseases is anticipated to increase the demand for autotransfusion devices. According to the records of the National Library of Medicine, worldwide, every 3 in 5 deaths is caused by cardiovascular disease, cancer, chronic lung problems, and diabetes.
  •  The Rising Number of Surgical Procedures Operated Across the World- Cell salvage and blood transfusions are critical components of blood conservation during every surgical operation. In addition, the increased blood transfusion diagnostics are done in order to detect any infection in the blood before the transfusion. Furthermore, the greater focus on ignoring the hazards connected with allogeneic transfusions, along with an expanding number of bleeding-intensive surgeries, is expected to propel overall market expansion over the coming years. Globally nearly 11% of worldwide disease requires surgical treatment. Furthermore, there are nearly 310 million surgical procedures are carried out every year.
  • Increase in the Number of People with Kidney Problems- Chronic kidney disease is a progressive illness that impacts more than 10% of the global population. Chronic kidney disease is more common in older adults, women, racial minorities, and individuals with diabetes and high blood pressure. Nearly 850 million people all over the world have developed some sort of kidney disease.
  •  Surge in Population Percentage of Old-Adult- According to the WHO, by 2030, every 1 in 6 people is likely to be aged 60 years or above. Moreover, between 2015-2050, the worldwide older population is to get double, from nearly 12% to 22%.
  •  Rising Need for Blood Transfusion- According to the World Health Organization, the global share of blood transfusion in children is 54%, and nearly 76% of adults above 60 years of age.

Challenges

  • Higher Prevalence of Minimally Invasive Surgery - Minimal invasion is highly adopted, and factors such as less pain, fast recovery, minimal blood loss, and higher comfort of patients are resulting higher number of people choosing it over traditional surgery. Therefore, it is likely to hamper the market’s growth.
  • Increased Use of Hemostatic Devices for Transfusions
  • Difficulty in Separating Contaminants from Blood

Autotransfusion Devices Market: Key Insights

Base Year

2022

Forecast Year

2023-2033

CAGR

~6%

Base Year Market Size (2022)

~USD 250 Million

Forecast Year Market Size (2033)

~USD 400 Million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Base Year

2024

Forecast Year

2025-2037

CAGR

6.7%

Base Year Market Size (2024)

USD 285.15 million

Forecast Year Market Size (2037)

USD 652.68 million

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4459
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of autotransfusion devices is estimated at USD 300.21 million.

The autotransfusion devices market size was valued at USD 285.15 million in 2024 and is poised to cross USD 652.68 million by the end of 2037, registering more than 6.7% CAGR during the forecast period i.e., between 2025-2037. Rise in geriatric population, growing cases of chronic disease, higher blood donation & blood transfusion and rise in surgery will impel the market growth.

Asia Pacific industry is anticipated to expand at the fastest CAGR through 2037, owing to entry of new industry players, and increasing acceptance of cell salvage technologies.

The major players in the market include ProCell Surgical Inc, .BD (Becton, Dickinson and Company), Fresenius SE & Co. KGaA, Medtronic, Beijing Jingjing Medical Equipment Co., Ltd., Haematonics Corporation, LivaNova PLC, Zimmer Biomet, SARSTEDT AG & Co. KG, Gen World Medical Devices.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample